B.C. Cancer Agency pulls funding for pricey thalidomide
July 28th, 2006 | Comments Off
The B.C. Cancer Agency will cease funding the drug thalidomide for new bone cancer patients, citing the notorious drug’s $2 million annual budget cost as “no longer tenable.” Of the 165 B.C. patients who have been prescribed the drug in the past year for multiple myeloma, those who are still on it will be grandfathered into the new policy effective …
Original post by Canada.com
(click on the author link above to see full post)